LOVENBERG WALTER M PHD 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Apr 27, 2012
Insider Transaction Report
Form 4
LOVENBERG WALTER M PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2012-04-25$2.19/sh+5,462$11,962→ 84,033 total - Exercise/Conversion
Stock Option (right to buy)
2012-04-25+5,462→ 0 totalExercise: $2.19Exp: 2012-05-03→ Common Stock (5,462 underlying)
Footnotes (1)
- [F1]This option is fully vested.